All Stories

  1. Health conspiracy theories: a scoping review of drivers, impacts, and countermeasures
  2. Can digital storytelling improve health outcomes for immigrant and refugee populations? A scoping review
  3. Religious beliefs and practices toward HPV vaccine acceptance in Islamic countries: A scoping review
  4. A Comprehensive Analysis of COVID-19 Misinformation, Public Health Impacts, and Communication Strategies: Scoping Review
  5. Political Leaders’ Communication Strategies during COVID-19 in Highly Infected Countries: A Scoping Review
  6. A Comprehensive Analysis of COVID-19 Misinformation, Public Health Impacts and Communication Strategies: A Scoping Review (Preprint)
  7. A Comparison of the Authoritarian Strategies Used by Brazil and Turkey to Tackle the COVID-19 Crisis
  8. Individual supported work placements (ReISE) for improving sustained return to work in unemployed people with persistent pain: study protocol for a cohort randomised controlled trial with embedded economic and process evaluations.
  9. Burden of diabetes and hyperglycaemia in adults in the Americas, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  10. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019
  11. Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019
  12. Changes in life expectancy and disease burden in Norway, 1990–2019: an analysis of the Global Burden of Disease Study 2019
  13. A Comparative Analysis of Public Hospital Pharmacy Systems in Norway and Pakistan: A Pilot Implementation of the American Society of Health-System Pharmacists’ (ASHP) Guidelines
  14. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019
  15. Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
  16. The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study
  17. The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019
  18. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  19. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study
  20. Metabolism and risk
  21. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
  22. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
  23. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
  24. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  25. Modeling Users’ Empowerment in E-Health Systems
  26. Turkey’s COVID-19 strategy: “the West is jealous of us”
  27. Global, regional, and national sex-specific burden and control of the HIV epidemic
  28. Mapping Anemia in Women: Global Trends and Inequality
  29. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019
  30. Fatal police violence by race and state in the USA, 1980–2019: a network meta-regression
  31. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  32. Tracking development assistance for health and for COVID-19
  33. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status
  34. Use of multidimensional item response theory methods for dementia prevalence prediction: an example using the Health and Retirement Survey and the Aging, Demographics, and Memory Study
  35. Domestic Violence Against Women in North African and Middle Eastern Countries: A Scoping Review
  36. Measuring routine childhood vaccination coverage in 204 countries and territories
  37. Child Mortality Trends and Targets: GBD 2019 Findings
  38. Mapping inequalities in exclusive breastfeeding in low- and middle-income countries, 2000–2018
  39. Public health utility of cause of death data: applying empirical algorithms to improve data quality
  40. Subnational mapping of HIV incidence and mortality among individuals aged 15–49 years in sub-Saharan Africa, 2000–18: a modelling study
  41. Tobacco Use and Risk Factors for Hypertensive Individuals in Kenya
  42. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study
  43. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study
  44. Mapping subnational HIV mortality in six Latin American countries with incomplete vital registration systems
  45. Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019
  46. The Burden of Dementia due to Down Syndrome, Parkinson’s Disease, Stroke, and Traumatic Brain Injury: A Systematic Analysis for the Global Burden of Disease Study 2019
  47. Mapping routine measles vaccination in low- and middle-income countries
  48. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
  49. Five insights from the Global Burden of Disease Study 2019
  50. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019
  51. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  52. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  53. Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17
  54. Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study
  55. Assessment of Norwegian physicians’ knowledge, experience and attitudes towards medical cannabis
  56. Under‐reporting of COVID ‐19 cases in Turkey
  57. Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17
  58. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  59. The Burden of Skin and Subcutaneous Diseases in the United States From 1990 to 2017
  60. Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
  61. Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017
  62. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  63. Department of Error
  64. Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990–2017
  65. death-dying-and-end-of-life-care-in-the-us-and-the-netherlands-a-scoping-review
  66. Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017
  67. Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
  68. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3
  69. Global trends of hand and wrist trauma: a systematic analysis of fracture and digit amputation using the Global Burden of Disease 2017 Study
  70. Global, Regional, and National Levels and Trends in Burden of Oral Conditions from 1990 to 2017: A Systematic Analysis for the Global Burden of Disease 2017 Study
  71. GBD 2016. Occupational Carcinogens Collaborators
  72. Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016
  73. Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016
  74. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  75. Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017
  76. Mapping child growth failure across low- and middle-income countries
  77. Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017
  78. Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017
  79. Mapping disparities in education across low- and middle-income countries
  80. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  81. Life expectancy and disease burden in the Nordic countries: results from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017
  82. Mapping 123 million neonatal, infant and child deaths between 2000 and 2017
  83. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
  84. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017
  85. The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017
  86. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050
  87. Department of Error
  88. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  89. A Scoping Review of Health Literacy Measurement Tools in the Context of Cardiovascular Health
  90. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  91. Global, regional, and national burden of suicide mortality 1990 to 2016: systematic analysis for the Global Burden of Disease Study 2016
  92. Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  93. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  94. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  95. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017
  96. The Role of Information and Communications Technology (ICT) in Enhancing Service Sector Productivity in Palestine
  97. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
  98. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease ...
  99. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  100. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  101. Measuring progress of the health-related Sustainable Development Goals for 195 countries
  102. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  103. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  104. Department of Error
  105. Alcohol use and attributable disease burden in 195
  106. Measuring performance_Healthcare Access_Quality Index for 195 countries and territories
  107. Department of Error
  108. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016
  109. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  110. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  111. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  112. Department of Error
  113. Opinions and attitudes of obstetricians and midwives in Turkey towards caesarean section and vaginal birth following a previous caesarean section
  114. Diabetes education program for people with type 2 diabetes: An international perspective
  115. ÖĞRETİM ELEMANLARINDA ÖRGÜTSEL SESSİZLİK ÜZERİNE NİTEL BİR ARAŞTIRMA
  116. A Cost Analysis Of Kidney Therapy Options
  117. Electronic Health Object
  118. A Cost Analysis of Kidney Replacement Therapy Options in Palestine
  119. Potential Cost-Effectiveness of Pneumococcal Conjugate Vaccine (PCV) in Turkey
  120. Healthcare of Aging Population of Kuwait
  121. Delayed use of healthcare services among the urban poor in Turkey
  122. A discussion of job dissatisfaction and burnout among public hospital physicians
  123. Overwhelming health expenditures among the poor in a transition economy: A case study from Turkey
  124. The Adoption of American Home Health Care Systems and its Developing Market in Turkey: What Do Physicians Think? A pilot Study in Turkey
  125. The Role of Public Relations Activities in Hospital Choice
  126. A Comparative Analysis of the European Union's and Turkey's Health Status: How Health-Care Services Might Affect Turkey's Accession to the EU
  127. Access to healthcare: Lessons from Turkey
  128. International Observer
  129. Analysis of the pharmaceuticals market and its technological development in Turkey
  130. National Health System Steps in Turkey
  131. Wasteful Use of Financial Resources in Public Hospitals in Turkey
  132. Job Dissatisfaction Among Public Hospital Physicians is a Universal Problem
  133. The Influence of Financial Officers on the Decision-Making Process in Health Facilities
  134. Benign Prostatic Hyperplasia: Cost and Effectiveness of Three Alternative Surgical Treatment Methods Used in a Turkish Hospital
  135. Physicians’ Concerns About Home Health Care in Turkey: How Supportive Are They?
  136. Conflict Management in Public University Hospitals in Turkey
  137. The Need for Time Management Training Is Universal: Evidence from Turkey
  138. Appropriateness of Admission and Length of Stay in a Turkish Military Hospital
  139. The Pharmaceutical Sales Rep/Physician Relationship in Turkey
  140. Knowledge, Attitudes, and Behavior Toward Sexually-Transmitted Infections in Turkish Sex Trade Workers
  141. Sex Workers and the Issues Surrounding Registration in Turkey
  142. Can Rural Telemedicine Help to Solve the Health Care Access Problems in Turkey?
  143. Sexual Harassment and Its Consequences
  144. PATIENTS' RIGHTS IN TURKEY
  145. Measurement of patient satisfaction in a public hospital in Ankara
  146. Measurement of Patient Satisfaction in a Public Hospital in Ankara
  147. What Patients Know About Their Rights in Turkey
  148. Student Utilization of Health Services at a University Hospital in Turkey
  149. Sexual Harassment of Female Nurses in a Hospital in Turkey